Molecule | Cat. No. | Species | Product Description | Host | Purity | Feature | Size&Price | Compare |
Claudin-18.2 | HCS-S278 |
|
Recombinant Monoclonal Anti-Claudin-18.2 Antibody, Mouse (3B10) | |||||
Claudin-18.2 | HCS-S279 |
|
Recombinant Monoclonal Anti-Claudin-18.2 Antibody, Mouse (12C11) | |||||
Claudin-18.2 | HCB-Y126 |
|
Monoclonal Anti-Claudin-18.2 Antibody, Mouse IgG1 (3B10) | Hybridoma |
Cat. No. | Product Description | Size&Price | Compare |
CAA-B002 | Claudin18.2 IHC 3B10 Kit |
Cat. No. | Product Description | Size&Price | Compare |
CHEK-ATP033 | HEK293/Human Claudin-18.2 Stable Cell Line |
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
CLDN 18.2 CAR-T | Cell therapy | Oncology/Cancer | Gastric Cancer,Pancreatic Cancer | IND | Global |
Claudin18.2×CD8+ T bsAb | Bispecific antibody | Oncology/Cancer | Gastric cancer,Pancreatic cancer,Oophoroma | IND | Global |
Claudin18.2 mAb | Monospecific antibody | Oncology/Cancer | Gastric cancer | Phase I | Global |
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
CLDN18.2 CAR-T - 01 | PhaseI | CAR | Nanobody | Solid Tumor | Advanced refractory gastrointestinal tumors |
CLDN18.2 VHH - 01 | Lead | Monoclonal | Nanobody | Solid Tumor | Gastric Cancer,Pancreatic cancer |
This web search service is supported by Google Inc.